Differentiating Tumor Progression from Pseudoprogression in Patients with Glioblastomas Using Diffusion Tensor Imaging and Dynamic Susceptibility Contrast MRI

Differentiation of Tumor Progression from Pseudoprogression in Patients with Posttreatment Glioblastoma Using Multiparametric Histogram Analysis

(2014) J. Cha et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Diagnostic Utility of Diffusion Tensor Imaging in Differentiating Glioblastomas from Brain Metastases

(2014) S. Wang et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Utility of Intravoxel Incoherent Motion MR Imaging for Distinguishing Recurrent Metastatic Tumor from Treatment Effect following Gamma Knife Radiosurgery: Initial Experience

(2014) D.Y. Kim et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Perspectives for immunotherapy in glioblastoma treatment

(2014) Gaetano Finocchiaro et al.   CURRENT OPINION IN ONCOLOGY

Parametric Response Maps of Perfusion MRI May Identify Recurrent Glioblastomas Responsive to Bevacizumab and Irinotecan

(2014) Domenico Aquino et al.   PLoS One

Prediction of Pseudoprogression in Patients with Glioblastomas Using the Initial and Final Area Under the Curves Ratio Derived from Dynamic Contrast-Enhanced T1-Weighted Perfusion MR Imaging

(2013) C.H. Suh et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Bevacizumab for the treatment of glioblastoma

(2013) Sajeel Chowdhary et al.   Expert Review of Neurotherapeutics

Morphologic MRI features, diffusion tensor imaging and radiation dosimetric analysis to differentiate pseudo-progression from early tumor progression

(2013) Ajay Agarwal et al.   JOURNAL OF NEURO-ONCOLOGY

Differentiation of True Progression from Pseudoprogression in Glioblastoma Treated with Radiation Therapy and Concomitant Temozolomide: Comparison Study of Standard and High-b-Value Diffusion-weighted Imaging

(2013) Hee Ho Chu et al.   RADIOLOGY

Diffusion-weighted MR Imaging for the Differentiation of True Progression from Pseudoprogression Following Concomitant Radiotherapy with Temozolomide in Patients with Newly Diagnosed High-grade Gliomas

(2012) Woong Jae Lee et al.   ACADEMIC RADIOLOGY

The Role of Preload and Leakage Correction in Gadolinium-Based Cerebral Blood Volume Estimation Determined by Comparison with MION as a Criterion Standard

(2012) J. L. Boxerman et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Pseudoprogression and Treatment Effect

(2012) Arman Jahangiri et al.   NEUROSURGERY CLINICS OF NORTH AMERICA

Percent Change of Perfusion Skewness and Kurtosis: A Potential Imaging Biomarker for Early Treatment Response in Patients with Newly Diagnosed Glioblastomas

(2012) Hye Jin Baek et al.   RADIOLOGY

Pseudoprogression in Patients With Glioblastoma Multiforme After Concurrent Radiotherapy and Temozolomide

(2011) Erkan Topkan et al.   AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS

Diagnostic Dilemma of Pseudoprogression in the Treatment of Newly Diagnosed Glioblastomas: The Role of Assessing Relative Cerebral Blood Flow Volume and Oxygen-6-Methylguanine-DNA Methyltransferase Promoter Methylation Status

(2011) D.-S. Kong et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Differentiation between Glioblastomas, Solitary Brain Metastases, and Primary Cerebral Lymphomas Using Diffusion Tensor and Dynamic Susceptibility Contrast-Enhanced MR Imaging

(2011) S. Wang et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Apparent Diffusion Coefficient Histogram Analysis Stratifies Progression-Free Survival in Newly Diagnosed Bevacizumab-Treated Glioblastoma

(2011) W.B. Pope et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Pseudoprogression and Pseudoresponse: Imaging Challenges in the Assessment of Posttreatment Glioma

(2011) L.C. Hygino da Cruz et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Support vector machine multiparametric MRI identification of pseudoprogression from tumor recurrence in patients with resected glioblastoma

(2011) Xintao Hu et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Parametric Response Map As an Imaging Biomarker to Distinguish Progression From Pseudoprogression in High-Grade Glioma

(2010) Christina Tsien et al.   JOURNAL OF CLINICAL ONCOLOGY

Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group

(2010) Patrick Y. Wen et al.   JOURNAL OF CLINICAL ONCOLOGY

Distinction between postoperative recurrent glioma and radiation injury using MR diffusion tensor imaging

(2010) Jun-Ling Xu et al.   NEURORADIOLOGY

Changes in Relative Cerebral Blood Volume 1 Month after Radiation-Temozolomide Therapy Can Help Predict Overall Survival in Patients with Glioblastoma

(2010) Rajiv Mangla et al.   RADIOLOGY

Posttreatment High-Grade Glioma: Usefulness of Peak Height Position with Semiquantitative MR Perfusion Histogram Analysis in an Entire Contrast-enhanced Lesion for Predicting Volume Fraction of Recurrence

(2010) Ho Sung Kim et al.   RADIOLOGY

Magnetic Resonance Perfusion and Permeability Imaging in Brain Tumors

(2009) Saulo Lacerda et al.   NEUROIMAGING CLINICS OF NORTH AMERICA

Posttreatment Recurrence of Malignant Brain Neoplasm: Accuracy of Relative Cerebral Blood Volume Fraction in Discriminating Low from High Malignant Histologic Volume Fraction

(2009) Emerson L. Gasparetto et al.   RADIOLOGY

Differentiation of Recurrent Glioblastoma Multiforme from Radiation Necrosis after External Beam Radiation Therapy with Dynamic Susceptibility-weighted Contrast-enhanced Perfusion MR Imaging

(2009) Ramon F. Barajas et al.   RADIOLOGY

Differentiation between glioblastomas and solitary brain metastases using diffusion tensor imaging

(2008) Sumei Wang et al.   NEUROIMAGE